Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Heart failure (HF) is a rapidly growing global public health problem. Since HF results in high mortality and re-hospitalization, new effective treatments are desired. Although it remains controversial, omega 3 polyunsaturated fatty acids (n-3 PUFAs), such as the eicosapentaenoic acid and docosahexaenoic acid, have been widely recognized to have benefits for HF. In a large-scale clinical trial regarding secondary prevention of HF by n-3 PUFA (GISSI-HF trial), the supplementation of n-3 PUFA significantly reduced cardiovascular mortality and hospitalization. Other small clinical studies proposed that n-3 PUFA potentially suppresses the ventricular remodeling and myocardial fibrosis, which thereby improves the ventricular systolic and diastolic function both in ischemic and non-ischemic HF. Basic investigations have further supported our understanding regarding the cardioprotective mechanisms of n-3 PUFA against HF. In these reports, n-3 PUFA has protected hearts through (1) anti-inflammatory effects, (2) intervention of cardiac energy metabolism, (3) modification of cardiac ion channels, (4) improvement of vascular endothelial response, and (5) modulation of autonomic nervous system activity. To clarify the pros and cons of n-3 PUFA on HF, we summarized recent evidence regarding the beneficial effects of n-3 PUFA on HF both from the clinical and basic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generally, the available data seem to support the positive impact of dietary n-3 PUFAs on blood pressure [20], congestive heart failure [25], and supplementation of more than one g/day−1 of n-3 PUFAs seem effective in lowering the risk of fatal cardiac events [21].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · cited 3×
“However, a recent large-scale clinical trial (REDUCE-IT; Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial) showed that a relatively high amount of n-3 PUFA supplementation (4 g/day) significantly reduced CVD events in patients with elevated serum triglyceride [16], and the beneficial effect o…”
BackgroundRovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120 · cited 1×
“An impaired autonomic tone is one risk-factor of a fatal arrhythmic event and sudden cardiac death in patients with dilated cardiomyopathy [100] and ischemic cardiomyopathy [101].”
BackgroundYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · cited 20×
“Several prior prospective observational studies and randomized control trials proved that consumption of fish or fish oil containing n-3 PUFA decreased IHD mortality (e.g., myocardial infarction (MI) and sudden cardiac death) in patients with or without pre-diagnosed CVD [2,19,20].”
BackgroundInfluential(1999) · PubMed · Cited by 2,062
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966 · cited 18×
“Several prior prospective observational studies and randomized control trials proved that consumption of fish or fish oil containing n-3 PUFA decreased IHD mortality (e.g., myocardial infarction (MI) and sudden cardiac death) in patients with or without pre-diagnosed CVD [2,19,20].”
BackgroundInfluentialEpidemiology and aetiology of heart failure
Ziaeian, B., & Fonarow, G. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.25 · Cited by 1,878
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717 · cited 2×
“Classically, eicosanoids originated from n-3 PUFA are known to enhance the production of anti-inflammatory cytokines at the site of inflammation, whereas essential n-6 PUFAs, such as AA, are considered as substrates of pro-inflammatory eicosanoids, which promote vascular permeability, leucocyte infiltration and activa…”
Background
Cited by
Algae as Food in Europe: An Overview of Species Diversity and Their Application
Mendes, M., Navalho, S., Ferreira, A., Paulino, C., Figueiredo, D., Silva, D., Gao, F., Gama, F., Bombo, G., Jacinto, R., et al. (2022) · Foods · doi:10.3390/foods11131871 · Cited by 234
Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
Remize, M., Brunel, Y., Silva, J. L., Berthon, J.-Y., & Filaire, E. (2021) · Marine Drugs · doi:10.3390/md19020113 · Cited by 214
“Generally, the available data seem to support the positive impact of dietary n-3 PUFAs on blood pressure [20], congestive heart failure [25], and supplementation of more than one g/day−1 of n-3 PUFAs seem effective in lowering the risk of fatal cardiac events [21].”
BackgroundBiomaterials from the sea: Future building blocks for biomedical applications
Wan, M.-C., Qin, W., Lei, C., Li, Q.-H., Meng, M., Fang, M., Song, W., Chen, J.-H., Tay, F., & Niu, L.-N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.028 · Cited by 171
“[327] with permission from the publisher; C is reproduced from Ref.”
BackgroundPatted, P. G., Masareddy, R. S., Patil, A. S., Kanabargi, R., & Bhat, C. T. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00667-5 · Cited by 149
Bilal, M., & Iqbal, H. M. N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.037 · Cited by 66
Barrea, L., Vetrani, C., Verde, L., Frías-Toral, E., Ceriani, F., Cernea, S., Docimo, A., Graziadio, C., Tripathy, D., Savastano, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040904 · Cited by 61
Rakotoarisoa, M., Angelov, B., Espinoza, S., Khakurel, K. P., Bizien, T., Drechsler, M., & Angelova, A. (2021) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.1c04706 · Cited by 58
PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling
Oppedisano, F., Mollace, R., Tavernese, A., Gliozzi, M., Musolino, V., Macrì, R., Carresi, C., Maiuolo, J., Serra, M. D. R., Cardamone, A., et al. (2021) · Nutrients · doi:10.3390/nu13092965 · Cited by 64
“Thanks to their properties, n-3 PUFAs reduce ventricular remodeling and myocardial fibrosis, improving systolic and diastolic ventricular function altered in HF [66].”
BackgroundOmega-3 fatty acids mediated Cellular signaling and its regulation in Human Health
Kar, A., Ghosh, P., Patra, P., Chini, D. S., Nath, A. K., Saha, J. K., & Patra, B. C. (2023) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2023.10.004 · Cited by 56
Nova, P., Pimenta‐Martins, A., Maricato, É., Nunes, C., Abreu, H., Coimbra, M. A., Freitas, A. C., & Gomes, A. (2023) · Molecules · doi:10.3390/molecules28124588 · Cited by 44
Moreira, A. S. P., da Costa, E., Melo, T., Sulpice, R., Cardoso, S. M., Pitarma, B., Pereira, R., Abreu, M. H., Domingues, P., Calado, R., et al. (2020) · Algal Research · doi:10.1016/j.algal.2020.101958 · Cited by 38
“…been widely associated with n -3 PUFAs, including anti-in fl ammatory properties, reduction of cardiovascular disease, and prevention of breast cancer and cancer-related complications [53 – 55], while n -6 PUFAs have been linked to the promotion of in fl ammatory processes and tumour growth [56].”
Moreira, A. S. P., da Costa, E. V., Melo, T., Lopes, D., Pais, A. C. S., Santos, S. A. O., Pitarma, B., Mendes, M., Abreu, H., Collén, P. N., et al. (2021) · Foods · doi:10.3390/foods10050914 · Cited by 38
“Lipids, despite their low content (less than 5% of the dry matter of several macroalgae) [3,8], are considered a valuable source of polyunsaturated fatty acids (PUFA), namely omega-3 (n-3) PUFA, known for their beneficial health impacts [9,10].”
BackgroundInfluentialMarine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry
Akram, W., Rihan, M., Ahmed, S., Arora, S., Ahmad, S., & Vashishth, R. (2023) · Marine Drugs · doi:10.3390/md21030193 · Cited by 39
Aveiro, S. S., Melo, T., Figueiredo, A. R. P., Domingues, P. M., Pereira, H., Maia, I. B., Silva, J., Domingues, M. R., Nunes, C., & Moreira, A. S. P. (2020) · Biomolecules · doi:10.3390/biom10101434 · Cited by 32
Gui, T., Li, Y., Zhang, S., Zhang, N., Sun, Y., Liu, F., Chen, Q., & Gai, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110306 · Cited by 29
Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure
Zheng, S., Qiu, M. R., Wu, J. H. Y., Pan, X., Liu, X., Sun, L., Zhu, H., Wu, J., & Huang, Y. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081616 · Cited by 29
Sun, G. Y., Appenteng, M. K., Li, R., Woo, T., Yang, B., Qin, C., Pan, M., Cieślik, M., Cui, J., Fritsche, K. L., et al. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08616-0 · Cited by 26
Yamagata, K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200403121952 · Cited by 27
The multidimensional benefits of eicosapentaenoic acid: from heart health to inflammatory control
Nassar, M., Jaffery, A., Ibrahim, B., Baraka, B., & Abosheaishaa, H. M. (2023) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-023-00265-6 · Cited by 26
“EPA and DHA intake was found to decrease the incidence of heart failure by 18–29%, while randomized controlled trials demonstrated that EPA and DHA therapy at doses ranging from 1 to 4 g per day significantly improved left ventricular ejection fraction (LVEF), a measure of heart function [38].”
BackgroundGao, Z., Zhang, D., Yan, X., Shi, H., & Xian, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.904250 · Cited by 22
“ω-3 PUFAs have various effects on the cardiovascular system and can provide multiple health benefits for the cardiovascular system (1, 2) via various mechanisms, such as reduction in blood lipids and inflammatory cell aggregation (3–10), and the reduction of triglycerides in the blood is thought to be the main benefit…”
BackgroundLipids and phenylketonuria: Current evidences pointed the need for lipidomics studies
Guerra, I. M. S., Ferreira, H. B., Neves, B., Melo, T., Diogo, L. M., Domingues, M. R., & Moreira, A. S. P. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108431 · Cited by 22
Plasma Phospholipidomic Profile Differs between Children with Phenylketonuria and Healthy Children
Guerra, I. M. S., Diogo, L. M., Pinho, M., Melo, T., Domingues, P. M., Domingues, M. R., & Moreira, A. S. P. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c01052 · Cited by 22
Lechner, K., Scherr, J., Lorenz, E., Lechner, B., Haller, B., Krannich, A., Halle, M., Wachter, R., Duvinage, A., & Edelmann, F. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01925-9 · Cited by 21
Lipoprotection in cardiovascular diseases
Benkhoff, M., & Polzin, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108747 · Cited by 21
Matsuo, N., Miyoshi, T., Takaishi, A., Kishinoue, T., Yasuhara, K., Tanimoto, M., Nakano, Y., Onishi, N., Ueeda, M., & Ito, H. (2021) · Nutrients · doi:10.3390/nu13020371 · Cited by 19
“Omega-3 PUFAs, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and oemga-6 PUFAs, such as arachidonic acid (AA) and dihomo-gamma-linolenic acid (DGLA), have been shown to have opposite effect [9].”
BackgroundMoreira, A. S. P., Gonçalves, J., Conde, T., Couto, D., Melo, T., Maia, I. B., Pereira, H., Silva, J., Domingues, M. R., & Nunes, C. (2022) · Algal Research · doi:10.1016/j.algal.2022.102756 · Cited by 20
Wichard, T., Mapelli‐Brahm, P., Barba, F. J., Domingues, R., Guttman, L., Hutárová, L., Loureiro, J. A., Unal, D., Koseoglu-Yilmaz, P., Zammit, G., et al. (2026) · Bioresource Technology · doi:10.1016/j.biortech.2026.134066 · Cited by 21
Bielecka-Dabrowa, A. M., Banach, M., Wittczak, A., Cicero, A. F. G., Kallel, A., Kubilius, R., Mikhailidis, D. P., Sahebkar, A., Stoian, A. P., Vinereanu, D., et al. (2023) · Archives of Medical Science · doi:10.5114/aoms/167799 · Cited by 20
“Multiple mechanisms of action have been considered, including: 1) anti-inflammatory properties of omega-3 fatty acids, which reduce cardiac remodelling caused by excessive interstitial fibrosis and systemic inflammatory process leading to cardiac cachexia; 2) metabolic alterations in cardiomyocytes accompanied by mito…”
Backgroundα-Linolenic Acid and Risk of Heart Failure: A Meta-Analysis
Wu, J., Qiu, M., Sun, L., Wen, J., Liang, D.-L., Zheng, S., & Huang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.788452 · Cited by 17
“Long-chain (LC) omega-3 polyunsaturated fatty acids (n-3 PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may play a protective role in the incidence and progression of HF, (5–7) through multiple mechanisms including anti-inflammation effects, improving cardiomyocytes’ energy metabolism end…”
BackgroundOmega-3 supplementation and outcomes of heart failure: A systematic review of clinical trials
Nomali, M., Heidari, M. E., Ayati, A., Tayebi, A., Shevchuk, O. O., Mohammadrezaei, R., Navid, H., Khayyatzadeh, S. S., Palii, S. M., Shiran, F. V., et al. (2024) · Medicine · doi:10.1097/md.0000000000036804 · Cited by 14
“[16,18,19] 22] However, further investigations are necessary to draw a definitive conclusion.”
BackgroundLazzarin, T., Martins, D., Ballarin, R. S., Monte, M. G., Minicucci, M. F., Polegato, B. F., & Zornoff, L. A. M. (2023) · Antioxidants · doi:10.3390/antiox12122067 · Cited by 11
“Subsequently, a broad scenario of ω 3-PUFA benefits has been explored, such as its role in the lipid profile, endothelial integrity, arrhythmia, and thrombosis [4].”
BackgroundInfluentialOils’ Impact on Comprehensive Fatty Acid Analysis and Their Metabolites in Rats
Stawarska, A., Jelińska, M., Czaja, J., Pacześniak, E., & Bobrowska‐Korczak, B. (2020) · Nutrients · doi:10.3390/nu12051232 · Cited by 11
“who highlighted some mechanisms of n-3 PUFA protective role in heart failure [67].”
BackgroundEurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
Starodubova, A. V., Chazova, I. E., Tutelyan, V. A., Nikityuk, D. B., Pavlovskaya, E. V., Кislyak, O. A., Blinova, N. V., Brumberg, A. A. B., Bubnova, M. G., Varaeva, Y. R., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-4-6-66 · Cited by 13
Liu, J., Meng, Q., Zheng, L., Yu, P., Hu, H., Zhuang, R., Ge, X., Liu, Z., Liang, X., & Zhou, X. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114521004979 · Cited by 10
“Previous study showed the cardioprotective mechanisms of n -3 PUFA against HF, including anti-inflammatory; intervention of cardiac energy metabolism; modification of cardiac ion channels; improvement of vascular endothelial and modulation of autonomic nervous system activity (41 – 43) .”
Tseng, P., Zeng, B., Hsu, C.-W., Liang, C., Stubbs, B., Chen, Y.-W., Chen, T., Lei, W., Chen, J.-J., Shiue, Y., et al. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100366 · Cited by 11
“…with higher doses and longer treatment durations across various diseases. n – 3 PUFA supplementation has demonstrated cardioprotective mechanisms in heart failure, including anti-in fl ammatory properties, improved endothelial function, and regulation of autonomic nervous system activity [93].”
Rausch, J., Gillespie, S. L., Orchard, T., Tan, A., & McDaniel, J. C. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102302 · Cited by 9
Obara, K., Kawaguchi, A., Inaba, R., Kawakita, M., Yamaguchi, R., Yamashita, H., Xu, K., Ou, G., Yamaki, F., Yoshioka, K., et al. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00362 · Cited by 9
Zheng, B., Wen, H., Zheng, B., Tang, S., Su, W., & Xiang, X. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2592256 · Cited by 12
“Omega-3 PUFAs lower the resting membrane potential of cardiac myocytes and shorten the refractory period by modulating ion channels (Sakamoto et al. 2019).”
Wei, W., Cheng, Z., Wang, X., Chang, M., Xie, D., Sun, C., Guo, X., & Li, B. (2025) · Food Reviews International · doi:10.1080/87559129.2025.2528083 · Cited by 14
“[108] This modulation occurs through the regulation of key transcription factors involved in lipid synthesis, such as sterol regulatory element-binding protein 1 (SREBP-1) and acetyl-CoA carboxylase (ACC), which decrease lipogenesis and promote fatty acid oxidation.”
Turan, B., Durak, A. T., Olğar, Y., & Tuncay, E. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04474-5 · Cited by 9
Jamshidi, S., Eskandari, Z., Ojaroodi, A. F., Keramat, S., & Stanek, A. (2025) · Nutrients · doi:10.3390/nu17142303 · Cited by 6
“A key mechanism includes activation of AMP-activated protein kinase (AMPK), which deacetylates and suppresses NF-κ B activity, ultimately reducing inflammation [21,176,177].”
Anti-ageing natural supplements: the main players in promoting healthy lifespan
Izadi, M., Sadri, N., Abdi, A., Zadeh, M. M. R., Jalaei, D., Ghazimoradi, M. M., Shouri, S., & Tahmasebi, S. (2024) · Nutrition Research Reviews · doi:10.1017/s0954422424000301 · Cited by 7
Li, G., Luo, C., Ge, T., He, K., Zhang, M., Hu, J., Zheng, B., Zou, R., & Fan, X. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01753-1 · Cited by 7
Bulut, S. D., Döndaş, N. Y., Koçhan, S., Arslan, B. N., Tamer, M. A., Osmani, M., Baraketi, S., Khwaldia, K., Zhang, Z., Döndaş, H. A., et al. (2026) · Marine Drugs · doi:10.3390/md24030116 · Cited by 5
“This alignment between experimentally observed biological effects and achievable exposure levels has contributed to the relatively strong translational evidence supporting the cardiovascular and metabolic benefits of marine-derived omega-3 fatty acids [74].”
InfluentialXu, K., Shimizu, M., Murai, C., Fujisawa, M., Ito, D., Saitoh, N., Nakagome, Y., Yamashita, M., Murata, A., Oikawa, S., et al. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.952 · Cited by 5
da Costa, B. B., Kunzmann, A., & Springer, K. (2025) · Discover Food · doi:10.1007/s44187-025-00603-3 · Cited by 9
“PUFAs cannot be synthesized by humans and are critical for health, playing key roles in reducing inflammation, supporting brain function, and preventing chronic disease [61, 66, 67].”
Davis, E. N., Dunbar, S. B., Higgins, M. K., Wood, K., Ferranti, E. P., Morris, A. A., & Butts, B. (2023) · Journal of Integrative Nursing · doi:10.4103/jin.jin_26_23 · Cited by 5
“…symptoms; hence the recent studies that note the use of omega-3-fatty acids to decrease inflammation to aid against further damage in HF. [10,14] There have been several clinical and observational trials that provide evidence that the intake of fish and fish oils decreased mortality…”
Manubolu, V. S., Budoff, M. J., & Lakshmanan, S. (2022) · Heart International · doi:10.17925/hi.2022.16.1.2 · Cited by 3
Xu, K., Shimizu, M., Yamashita, T., Fujiwara, M., Oikawa, S., Ou, G., Takazakura, N., Kusakabe, T., Takahashi, K., Kato, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62578-y · Cited by 4
Liu, X., Zhao, W., Bao, Y., Gu, Y., Tao, S., Monroig, Ó., Navarro, J. C., Zhu, T., Sun, P., Zhou, Q., et al. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743456 · Cited by 4
Beyond conventional care: exploring complementary and alternative medicine for autoimmune disorders
Katrib, M., Hamdan, Z., Serhal, J., Hayek, F., Makarem, N. N., & Rida, M. A. (2025) · Reumatologia/Rheumatology · doi:10.5114/reum/195015 · Cited by 4
“Omega-3 fatty acids are polyunsaturated fatty acids mainly derived from marine resources [23]; they are also available as dietary supplements.”
Pesapane, A., Scisciola, L., Basilicata, M. G., Fontanella, R. A., Balzano, N., Capuano, A., Zia, A., Arshad, M., Ulfat, Z., Tortorella, G., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03033-8 · Cited by 2
“…studies also demonstrated that omega-3 FAs may have a dual role in modulating inflammation by both inhibiting pro-inflammatory pathways, such as NF-κB and the NLRP3 inflammasome, and activating anti-inflammatory signalling pathways, such as the transcriptional activation of PPAR α/γ [47].”
Prokopenko, E. V., Орлова, С. В., & Никитина, Е. А. (2022) · Medical alphabet · doi:10.33667/2078-5631-2022-16-93-101 · Cited by 3
Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review
Meng, Y., Cui, X., Li, S., & Jin, C. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401078 · Cited by 2
Metabolome and microbiome analyses reveal the efficacy of Shen‐Fu formula in treating heart failure
Li, N., Huang, Y., Chen, F., Yin, Z., Wang, X. Q., & Zhang, K. (2024) · Biomedical Chromatography · doi:10.1002/bmc.6032 · Cited by 1
Sidiartha, I. G. L., Vedaswari, P. D., & Suryawan, I. W. B. (2020) · Malaysian Journal of Nutrition · doi:10.31246/mjn-2019-0132 · Cited by 1
“Omega-3 fatty acids, especially their active metabolites, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been known to have several beneficial effects on health (Gammone et al., 2019; Sakamoto et al., 2019).”
BackgroundEffects of omega-3 fatty acids, vitamins, and chelation therapy in patients with heart diseases
Joo, S.-J. (2021) · Journal of Medicine and Life Science · doi:10.22730/jmls.2021.18.1.1 · Cited by 1
The Modern Aspects of Nutrition during Chronic Heart Failure
Salikova, S. P., Grinevich, V. B., & Vlasov, A. A. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-196-12-62-73 · Cited by 2
Lv, L., Guo, Y., Zheng, Z., & Li, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-69874-7 · Cited by 1
“Furthermore, omega-3 PUFAs are particularly beneficial for patients with HF, as they can reduce ventricular remodeling and myocardial fibrosis, and improve the contractile and relaxation functions of the ventricles 53 .”
BackgroundAjith, T. A. (2024) · Journal of advanced health research & clinical medicine. · doi:10.4103/jhcr.jhcr_10_23 · Cited by 1
Impact of omega-3 fatty acids consumption on selected aspects related to cardiovascular diseases
Sławiński, A., Klein, P., & Górecka, Z. M. (2025) · Environmental Medicine · doi:10.26444/ms/196089 · Cited by 1
Defining the Role of Icosapent Ethyl in Clinical Practice
Chatterjee, S., Hajra, A., Bandyopadhyay, D., Ghosh, R. K., & DEEDWANIA, P. C. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00402-4 · Cited by 1
Novotny, K., Fritz, K., & Parmar, M. S. (2021) · StatPearls · Cited by 2
Appenteng, M. K. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/85765 · Cited by 1
Lechner, K., Scherr, J., Lorenz, E., Lechner, B., Haller, B., Halle, M., Wachter, R., Duvinage, A., & Edelmann, F. (2021) · Research Square · doi:10.21203/rs.3.rs-551004/v1
Bhattacharjee, B., Das, P., Ikbal, A. M. A., Baidya, R., & Choudhury, A. (2021) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2021.130518
استخلاص زيت الاسماك ومخلفاتها بتقنيات حديثة ودراسة صفاته النوعية: دراسة مرجعية
الحلفي, أ. ر. س., الشطي, ص. م. ح., & المطوري, ا. ع. ا. ع. ا. (2023) · مجلة علوم البحار والتقنيات البيئية · doi:10.59743/jmset.v9i2.156
Fatty acid tissue composition in mice fed diets containing varying levels of Omega-3 fatty acids
Hussein, N., Dahms, I., & Salem, N. (2025) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2025.102688
Tjandrawinata, R. R., Vencio, I. C., Nugroho, A. B. M., Hartanto, J., Widjanarko, N. D., & Nurkolis, F. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01868-5
“…cytokines in general circulation, improvement in the vascular function, and decreases in multiple biochemical risk factors of atherosclerosis [15, 70], all in concordance with the physiological benefits observed in marine animals, which reinforces the approach in standardizing supplements with…”
InfluentialTrefzer, C., Neumann, P.-A., & München, T. U. (2024)
Rakotoarisoa, M. (2021) · theses.fr (ABES) · doi:10.70675/7bf6365czfebbz4b3az9400z0a82f6d9364f
Wang, S., Li, J., Song, C., Li, Q., Yang, H., & Chen, M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178863
The Role of Diet and Nutrition in Heart Failure Care
Kasprzak, M., Godyń-Müller, K., Grześkowiak, M., Pelant, H., Zeigner, M., Błaszczyk, J., Kulak, B., Brzeziński, M., Majchrzak, Z., & Pierzyńska, K. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.93.72672
“Omega-3 polyunsaturated fatty acids also contribute to mitochondrial health by modifying the phospholipid composition of the mitochondrial membrane as it reduces myocardial oxygen consumption and provides protection against cell apoptosis (Sakamoto et al., 2019).”
Marine proteins and fatty acids based on food products
Umayangani, S., Thilakarathna, R. C. N., Anna, T., Choong, C. Y., Silva, I. D., Lee, Y., Silva, M., & Chandrapala, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29190-6.00017-9
da Costa, B. B. (2026) · Media (https://www.suub.uni-bremen.de/) · doi:10.26092/elib/6443
Metadata
- Authors
- Sakamoto, A., Saotome, M., Iguchi, K., & Maekawa, Y.
- Affiliations
- Hamamatsu University (JP)
- Corresponding author
- Saotome, Masao
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-08-18
- Volume
- 20
- Issue
- 16
- Pages
- 4025
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6719114
- OpenAlex
- W2968977140
- Cited by
- 73
- References
- 114
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 16 · 2020: 10
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (JP16K09428, JP18K08065)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure, omega-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid, cardioprotection, ventricular remodeling, myocardial fibrosis, anti-inflammatory activity, myocardial energy metabolism, cardiac ion channels, endothelial function, autonomic nervous system, GISSI-HF trial, cardiovascular mortality, hospitalization
- MeSH terms
- Animals, Cardiotonic Agents, Clinical Trials as Topic, Heart Failure, Humans, Fatty Acids, Omega-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.